Bottom line
JIRE vs EFAX: the short answer
JIRE (JPMorgan International Research Enhanced Equity ETF) and EFAX (State Street(R) SPDR(R) MSCI EAFE Fossil Fuel Reserves Free ETF) share a meaningful slice of their top holdings — about 56% by weight.
But EFAX is far broader, holding 647 positions to 214 for JIRE, so beyond the top names it adds exposure JIRE doesn't have.
EFAX is cheaper at 0.2% vs 0.24% — a difference of $4.00 a year per $10,000 invested.
Over five years, JIRE returned +9.7% a year vs +8.4% for EFAX.
Updated Nov 19, 2026
JIRE vs EFAX side by side
| JIRE | EFAX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | J.P. Morgan | SPDR (State Street) |
| Category | International Stock | International Stock |
| Expense ratio | 0.24% | 0.2% |
| Annual cost per $10k | $24 | $20 |
| 10-yr cost on $10k (prospectus) | $363 | $255 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +32.1% | +30.9% |
| 5-yr return (annualized) | +9.7% | +8.4% |
| 10-yr return (annualized) | +8.2% | — |
| Best quarter | +17.8% | +16.8% |
| Worst quarter | −23.4% | −22.1% |
| Net assets (fund) | $11.2B | $502.7M |
| Number of holdings | 214 | 647 |
| Portfolio turnover | 25% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JIRE | EFAX | Difference |
|---|---|---|---|
| 2025 | +32.1% | +30.9% | +1.2% |
| 2024 | +3.0% | +5.1% | −2.1% |
| 2023 | +19.7% | +18.2% | +1.5% |
| 2022 | −13.7% | −16.9% | +3.2% |
| 2021 | +12.9% | +10.7% | +2.2% |
| 2020 | +5.4% | +9.5% | −4.1% |
| 2019 | +22.0% | +22.9% | −0.9% |
| 2018 | −14.7% | −14.4% | −0.3% |
| 2017 | +23.3% | +24.7% | −1.4% |
Source: Fund prospectus bar charts
Holdings overlap
14 of JIRE's top 25 holdings also appear in EFAX's top 25.
| Holding | JIRE | EFAX |
|---|---|---|
| ASML Holding NV | 3.48% | 3.80% |
| Siemens AG | 1.78% | 1.19% |
| AstraZeneca plc | 1.69% | 1.41% |
| HSBC Holdings plc | 1.54% | 1.62% |
| Allianz SE | 1.51% | 0.89% |
| Banco Santander SA | 1.36% | 0.98% |
| Nestle SA | 1.33% | 1.32% |
| Roche Holding AG | 1.32% | 1.44% |
| Sumitomo Mitsui Financial Group, Inc. | 1.22% | 0.70% |
| Novartis AG | 1.22% | 1.43% |
| Toyota Motor Corp. | 1.12% | 0.79% |
| Iberdrola SA | 1.09% | 0.75% |
| Tokyo Electron Ltd. | 1.04% | 1.06% |
| UBS Group AG | 0.97% | 0.78% |
Source: SEC Form N-PORT
JIRE top 10
- ASML Holding NV — 3.48%
- Siemens AG — 1.78%
- AstraZeneca plc — 1.69%
- Shell plc — 1.55%
- HSBC Holdings plc — 1.54%
- Allianz SE — 1.51%
- Banco Santander SA — 1.36%
- UniCredit SpA — 1.33%
- Nestle SA — 1.33%
- Roche Holding AG — 1.32%
EFAX top 10
- ASML Holding NV — 3.80%
- State Street Global Advisors — 2.02%
- HSBC Holdings PLC — 1.62%
- Roche Holding AG — 1.44%
- Novartis AG — 1.43%
- AstraZeneca PLC — 1.41%
- Nestle SA — 1.32%
- Siemens AG — 1.19%
- Tokyo Electron Ltd — 1.06%
- Mitsubishi UFJ Financial Group Inc — 1.05%
FAQ
What is the difference between JIRE and EFAX?
Which is cheaper, JIRE or EFAX?
Should I own both JIRE and EFAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.